{"nct_id":"NCT02663752","title":"A Phase II Pilot Study to Assess the Presence of Molecular Factors Predictive for Hematologic Response in Myelodysplastic Syndrome Patients Receiving Deferasirox Therapy.","status":"TERMINATED","status_verified_date":"2018-07","start_date":"2016-05-30","start_date_type":"ACTUAL","primary_completion_date":"2016-07-01","primary_completion_date_type":"ACTUAL","completion_date":"2016-07-01","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}